Abstract

Cumulative distribution of patients by change in FVC % predicted in the INPULSIS trials of nintedanib in patients with idiopathic pulmonary fibrosis

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call